Eight weeks post-injection, 103 CSC cells successfully formed a tumor (2/4), while non-CD44+/CD24- tumor cells failed to form tumors until attaining 106 cells (1/4) (P<0.05, Fisher’s extract test, Fig. 1B1 and B2). The gene discussed is CD24; the disease is neoplasm.